LifeWave patches are not FDA approved. The company’s products, including the popular X39 patch, are sold as general wellness products rather than as FDA-cleared medical devices or approved drugs. Despite marketing language that references stem cell activation, peptide elevation, and various health improvements, none of these claims have gone through the FDA approval process.
What LifeWave Claims vs. What FDA Approval Means
LifeWave markets its X39 patch as a “phototherapy” product that reflects certain wavelengths of light back into the body, which the company says elevates a copper peptide called GHK-Cu. This peptide, LifeWave claims, then “activates your stem cells.” The company sells additional patches with names suggesting they target energy, sleep, pain relief, and other health outcomes.
FDA approval is a specific regulatory designation. It means a product has been reviewed through a formal process involving clinical trials, safety data, and evidence of effectiveness for a stated medical purpose. LifeWave patches have not undergone this process for any of their claimed benefits. The distinction matters because without FDA approval or clearance, no regulatory body has independently verified that these patches do what the company says they do.
It’s worth noting that registering a manufacturing facility with the FDA is not the same thing as receiving approval. The FDA itself states plainly: “Registration of a device establishment, assignment of a registration number, or listing of a medical device does not in any way denote approval of the establishment or its products by FDA.” If a seller points to FDA registration as evidence of legitimacy, that claim is misleading.
The Evidence Behind the Patches
The clinical evidence supporting LifeWave’s claims is thin. The most cited study is a pilot published in the International Journal of Healing and Caring, which enrolled just 15 people between the ages of 40 and 65. Participants wore the X39 patch for 8 to 12 hours a day over one week, and researchers measured amino acid levels, blood pressure, sleep quality, and self-reported vitality.
The study reported statistically significant changes in several amino acids and inflammatory markers, along with improvements in sleep, blood pressure, short-term memory, and feelings of vitality. On the surface, that sounds promising. But a 15-person study with no control group, no placebo comparison, and a one-week timeline does not meet the standard required for FDA approval or for drawing reliable medical conclusions. Effects this small in sample size can easily reflect placebo responses, natural day-to-day variation, or statistical noise. For context, FDA drug approvals typically require multiple trials involving hundreds or thousands of participants, with rigorous placebo controls.
Independent scientists have raised concerns about the plausibility of the proposed mechanism itself. The idea that a patch reflecting body heat as light could meaningfully raise levels of a specific copper peptide in the bloodstream, and that this peptide would then “activate” stem cells in a clinically useful way, has not been validated in peer-reviewed research outside of LifeWave-affiliated studies. As one stem cell researcher noted, the story “has holes” at multiple points in the chain of logic.
FDA’s Position on Stem Cell Marketing
The FDA has taken a clear stance on products marketed with stem cell claims. The agency warns consumers directly: “There continues to be broad marketing of unapproved products considered regenerative medicine therapies that are intended for the treatment or cure of a wide range of diseases or medical conditions. These products require FDA licensure/approval to be marketed to consumers.”
The agency goes further, cautioning that companies sometimes point to facility registration or entries in the clinicaltrials.gov database to imply their products are FDA-compliant. The FDA calls this “often false,” adding that “if you are being charged for these products or offered these products outside of a clinical trial, you are likely being deceived and offered a product illegally.”
LifeWave navigates around these restrictions by positioning its patches as wellness products rather than medical treatments. This classification allows the company to sell them without FDA approval, but it also means the company cannot legally claim its products treat, cure, or prevent any disease.
FTC Action Against LifeWave Distributors
While the FDA hasn’t taken public enforcement action against LifeWave directly, the Federal Trade Commission has targeted the company’s distribution network. In April 2026, the FTC filed a complaint against senior-level LifeWave distributors Steven and Gina Merritt, alleging they deceived consumers about how much money they could earn selling LifeWave products and recruiting new participants.
The FTC complaint revealed striking numbers from LifeWave’s own income disclosure: 79% of active participants earned nothing in commission payments in 2024. At most, only 0.035% of active participants earned more than $25,000 per week. LifeWave operates as a multi-level marketing company, which means much of its sales activity runs through independent distributors who have a financial incentive to promote the products, sometimes with exaggerated health or income claims.
The Merritts agreed to a settlement prohibiting them from misrepresenting potential earnings. This type of enforcement action doesn’t directly address the product’s effectiveness, but it signals the kind of environment surrounding its marketing.
What This Means if You’re Considering LifeWave
LifeWave patches occupy a gray zone in the wellness market. They are not illegal to sell, but they carry no FDA approval, no robust clinical evidence, and no regulatory verification that they deliver on their marketed benefits. The single pilot study supporting the X39 patch would not meet even the preliminary evidence threshold most scientists use to consider a treatment promising.
The patches are sold at a premium, often through distributors who earn commissions on sales. That financial structure can make it difficult to separate genuine testimonials from motivated marketing. If someone tells you the product is “registered with the FDA” or points to a small study as proof, those claims deserve scrutiny. Registration is not approval, and a 15-person study without a placebo group is not evidence of effectiveness.